SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)

NACompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
SclerodermaSystemic Sclerosis
Interventions
BEHAVIORAL

SPIN-SELF Program

The SPIN-SELF program utilizes social modelling through educational videos of scleroderma patients who describe their own challenges and what they have done to cope with living with scleroderma, as well as videos of patients and health professionals who teach key self-management techniques. The program includes sections on general self-management skills, including goal-setting and self-monitoring), progress tracking, sharing goals and progress with friends and family, and patient stories of experiences with using self-management techniques to cope with SSc symptoms. The program's 9 modules focus on (1) coping with pain; (2) skin care, finger ulcers and Raynaud's; (3) sleep problems; (4) fatigue; (5) gastrointestinal symptoms; (6) itch; (7) managing emotions and stress; (8) coping with body image concerns due to disfigurement; and (9) effective communication with healthcare providers.

Trial Locations (1)

H3T 1E3

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Lady Davis Institute

OTHER

NCT04246528 - SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF) | Biotech Hunter | Biotech Hunter